Who We Are
The Aptamer Group of companies focuses on the development of aptamer technologies. We develop nucleic acid aptamers for use in research & development, biomarker discovery, diagnostics or therapeutic developments. Aptamers are short ssDNA or ssRNA sequences that offer high-affinity and specificity to virtually all types of targets. Aptamers are versatile, cost effective and offer a complementary or alternative solution to antibodies. We have over 60 years combined expertise in the development of nucleic acid aptamers to peptides, proteins, cells, tissue samples, micro-organisms and small molecules.
We strive to be the leading supplier of aptamer-based technologies delivering transformational solutions to the life science market.
At the heart of Aptamer Group is the passion to deliver powerful science through discipline and dedication. We are driven by innovation and the desire to develop transformational technology. We are committed to offering the best possible service to our customers and provide access to aptamer technologies across a wide range of disciplines.
Our know-how and experience make us one of the leading aptamer suppliers world-wide.
We are entrepreneurial in our vision working with customers to improve, innovate and add value to their projects.
We believe firmly in partnership, collaboration and delivering excellence by interdisciplinary research and development.